Shorts just sell 200,000-500,000 shares a day in the last 2-3 minutes to keep the price low and then pay losers to post lies all day on the Yahoo MB, nope nothing illegal to see here.
and hopefully punish the lying shorts that have not yet exited. 371 first for $50-100MM up front with milestones and 10% royalty with no development costs. That will buy another year+ to prove that either 334 or 811 works and then they partner that one and get a large up front, or acquisition at $5-10+ depending on how strong (results) and how long ARNA holds 334, 371 and 811. That's how the ARNA shareholders win, if we win...Axovant is another wild card and Belviq CVOT could be the icing on the cake (or not).
thanks S9, it's good to see a valuable poster in the cess pool of garbage posts, Fudsters and pumpers.
New article out. Read and weep shorts!
3.5 MM in revs, 2.5 MM in product costs and they owe Eisai $13.6MM? You don't need to be a financial genius to understand ARNA needs major cost reductions including selling that money-losing plant in Switzerland and about 75% of the employees. They should have done this 1-2 years ago. Time is running short, we need action!!!
Uneducated with no real job prospects? Evil? Angry? Loser? Nothing better to do? Short? Doing a public service warning unsuspecting shareholders? Trying to buy low? Crazy? Fired/disgruntled? Did I miss anything?
Shareholders (OWNERS) demand action to make the stock price go up, not to continue supporting the failed people (business execs and BOD) and policies of the past. Keep a few scientists if we must. All others should be focused on doing deals (partnerships, or acquisition, not dilution deals) and developing drugs and maybe 1-2 bean counters, but not the $400,000 variety. A decent controller should cost no more than $140,000. People need to start performing!!!
Nice find and highly positive for ARNA and AXON. I need to add AXON to the peer group of ACAD, ICPT and GWPH. If ARNA just had decent management the stock might look like any one of these stocks. Valuation should certainly be more similar to at least one of these companies that are ALL valued in the $BB's
demand for a non-opiod pain med is very high, very large deals for phase I products and companies are happening every day. We will see. They might have to settle for $25MM up front and then $25-50 for moving into phase IIB/III, but there is a lot of money out there chasing these types of compounds. More evidence would help in the up front cash, but should not prohibit a reasonable deal.
Also regarding your recent fixation with dilution, management has a strong personal incentive to boost the share price, not to destroy it with low-priced dilution, debt, converts, warrants. They have plenty of cash for now IMO. More would be better, but not at this price/cost.
Amit effing Munshi, who the heck is he? Never heard of any of the #$%$ companies he worked for and the chart of his current company looks like ARNA. What a huge disappointment. Where do I go to get my $ back from Jack Lief the liar and this awful BOD. I guess they found another stooge to keep themselves employed.
I have a bad feeling that Amit will be following the BOD's failed plans. I would prefer that they all resign and let him run the company. Take a hike Harry, you were no better than Jack Thief. ARNA said nothing about anything for almost 30 minutes.
for coughing. Obesity, inflammation, opiod abuse, PAH...coughing??? 500MM vs. $1.25 BB. I report, you decide.